WeVote
Log In

Bill

Bill

HB 182

Genetic Information Amendments

2026 General Session Introduced by Walt Brooks and 1 co-sponsor

HB 182 strengthens Utah genetic privacy protections by regulating collection, use, and sharing of genetic data while balancing medical innovation and discrimination prevention concerns.

Senate/ placed on 3rd Reading Calendar table
#geneticcounselors #healthcare #healthcarefacilities #healthcareprofessionals #healthcarestatistics #healthandhumanservices #laborandemployment
0
WeVote Research Nonpartisan
Bill Summary · HB 182

Legislative bill overview

HB 182 amends Utah's genetic information privacy laws to establish new protections and regulations around how genetic data can be collected, used, and shared. The bill passed its second reading in the Senate on February 5, 2026, and is currently scheduled for third reading consideration. The exact provisions require examination of the bill's full text, but genetic information amendments typically address consent requirements, data security, and limitations on use by insurers, employers, or other entities.

Why is this important

Genetic information is uniquely sensitive personal data that can reveal predispositions to serious health conditions and affect employment, insurance eligibility, and family members. As genetic testing becomes more widespread and affordable, legislative frameworks become critical to prevent discrimination and misuse while balancing legitimate medical, research, and public health interests. Utah's approach could serve as a model for other states or influence how genetic data flows between consumers, healthcare providers, and third parties.

Potential points of contention

  • Scope of protections vs. medical innovation: Defining which entities (insurers, employers, life insurance companies, employers in specific industries) can or cannot access genetic information may conflict with arguments that such restrictions limit beneficial research or fair risk assessment
  • Consumer consent mechanisms: Determining whether broad consent is sufficient or if ongoing/specific consent is required for each use could impact genetic testing accessibility and cost
  • Enforcement and penalties: Questions about oversight agency authority, penalty severity, and whether private rights of action are included could significantly affect real-world compliance and remedy availability

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.